Pharmacy advate antihemophilic factor, recombinant 2000UNT/VIL INJ
Ended Awarded Last action
- Contract number
- 36C25925F0172
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI DDEVYUAXJ624
- Awarding agency
-
Veterans Integrated Service Network 19
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $10,784
Award facts
- Contract value 100% obligated
- $10,783.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Lexington, MA 02421, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$5,392 | |
| Original award | $16,176 |
About this award
This is a delivery order contract awarded by the Veterans Integrated Service Network 19 (VISN 19), a civilian agency, to Takeda Pharmaceuticals America Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. The contract is for the delivery of ADVATE Antihemophilic Factor, Recombinant, 2000 unit/vial injection, with a ceiling value of $10,783.80 and a completion date of January 17, 2025.
The contract is placed under the General Services Administration (GSA) Pharmaceuticals and Drugs Schedule (FSS-61-IB), a federal contract vehicle that enables federal agencies to procure essential pharmaceutical products. Takeda Pharmaceuticals America Inc. holds a significant Blanket Purchase Agreement (BPA) with the Department of Veterans Affairs (VA) National Acquisition Center, valued at $131,039,520.00, which further demonstrates the company's strategic approach to supporting the federal government's healthcare needs across multiple therapeutic areas.
Quick answers
Who was awarded contract 36C25925F0172?
36C25925F0172 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 19 (Veterans Health Administration) on January 15, 2025.
How much is contract 36C25925F0172 worth?
The government has obligated $10,784 on 36C25925F0172.
Is contract 36C25925F0172 an order under another contract?
Yes. 36C25925F0172 is a delivery order under V797D50492, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25925F0172 competed?
The extent of competition for 36C25925F0172 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award